Global CAR-T Cellular Immunotherapy Drug Supply, Demand and Key Producers, 2023-2029

Page: 80

Published Date: 02 Sep 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global CAR-T Cellular Immunotherapy Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies the global CAR-T Cellular Immunotherapy Drug demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for CAR-T Cellular Immunotherapy Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CAR-T Cellular Immunotherapy Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global CAR-T Cellular Immunotherapy Drug total market, 2018-2029, (USD Million)
Global CAR-T Cellular Immunotherapy Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: CAR-T Cellular Immunotherapy Drug total market, key domestic companies and share, (USD Million)
Global CAR-T Cellular Immunotherapy Drug revenue by player and market share 2018-2023, (USD Million)
Global CAR-T Cellular Immunotherapy Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global CAR-T Cellular Immunotherapy Drug total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global CAR-T Cellular Immunotherapy Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Kite Pharma, Bristol Myers Squibb and Fosun Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CAR-T Cellular Immunotherapy Drug market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global CAR-T Cellular Immunotherapy Drug Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global CAR-T Cellular Immunotherapy Drug Market, Segmentation by Type
CD19-Targeted
BCMA-Targeted

Global CAR-T Cellular Immunotherapy Drug Market, Segmentation by Application
Multiple Myeloma
Non-Hodgkin lymphoma
Leukemia

Companies Profiled:
Novartis AG
Kite Pharma
Bristol Myers Squibb
Fosun Pharma

Key Questions Answered
1. How big is the global CAR-T Cellular Immunotherapy Drug market?
2. What is the demand of the global CAR-T Cellular Immunotherapy Drug market?
3. What is the year over year growth of the global CAR-T Cellular Immunotherapy Drug market?
4. What is the total value of the global CAR-T Cellular Immunotherapy Drug market?
5. Who are the major players in the global CAR-T Cellular Immunotherapy Drug market?

Table of Contents

1 Supply Summary
    1.1 CAR-T Cellular Immunotherapy Drug Introduction
    1.2 World CAR-T Cellular Immunotherapy Drug Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World CAR-T Cellular Immunotherapy Drug Total Market by Region (by Headquarter Location)
        1.3.1 World CAR-T Cellular Immunotherapy Drug Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States CAR-T Cellular Immunotherapy Drug Market Size (2018-2029)
        1.3.3 China CAR-T Cellular Immunotherapy Drug Market Size (2018-2029)
        1.3.4 Europe CAR-T Cellular Immunotherapy Drug Market Size (2018-2029)
        1.3.5 Japan CAR-T Cellular Immunotherapy Drug Market Size (2018-2029)
        1.3.6 South Korea CAR-T Cellular Immunotherapy Drug Market Size (2018-2029)
        1.3.7 ASEAN CAR-T Cellular Immunotherapy Drug Market Size (2018-2029)
        1.3.8 India CAR-T Cellular Immunotherapy Drug Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 CAR-T Cellular Immunotherapy Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 CAR-T Cellular Immunotherapy Drug Major Market Trends

2 Demand Summary
    2.1 World CAR-T Cellular Immunotherapy Drug Consumption Value (2018-2029)
    2.2 World CAR-T Cellular Immunotherapy Drug Consumption Value by Region
        2.2.1 World CAR-T Cellular Immunotherapy Drug Consumption Value by Region (2018-2023)
        2.2.2 World CAR-T Cellular Immunotherapy Drug Consumption Value Forecast by Region (2024-2029)
    2.3 United States CAR-T Cellular Immunotherapy Drug Consumption Value (2018-2029)
    2.4 China CAR-T Cellular Immunotherapy Drug Consumption Value (2018-2029)
    2.5 Europe CAR-T Cellular Immunotherapy Drug Consumption Value (2018-2029)
    2.6 Japan CAR-T Cellular Immunotherapy Drug Consumption Value (2018-2029)
    2.7 South Korea CAR-T Cellular Immunotherapy Drug Consumption Value (2018-2029)
    2.8 ASEAN CAR-T Cellular Immunotherapy Drug Consumption Value (2018-2029)
    2.9 India CAR-T Cellular Immunotherapy Drug Consumption Value (2018-2029)

3 World CAR-T Cellular Immunotherapy Drug Companies Competitive Analysis
    3.1 World CAR-T Cellular Immunotherapy Drug Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global CAR-T Cellular Immunotherapy Drug Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for CAR-T Cellular Immunotherapy Drug in 2022
        3.2.3 Global Concentration Ratios (CR8) for CAR-T Cellular Immunotherapy Drug in 2022
    3.3 CAR-T Cellular Immunotherapy Drug Company Evaluation Quadrant
    3.4 CAR-T Cellular Immunotherapy Drug Market: Overall Company Footprint Analysis
        3.4.1 CAR-T Cellular Immunotherapy Drug Market: Region Footprint
        3.4.2 CAR-T Cellular Immunotherapy Drug Market: Company Product Type Footprint
        3.4.3 CAR-T Cellular Immunotherapy Drug Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: CAR-T Cellular Immunotherapy Drug Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: CAR-T Cellular Immunotherapy Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: CAR-T Cellular Immunotherapy Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: CAR-T Cellular Immunotherapy Drug Consumption Value Comparison
        4.2.1 United States VS China: CAR-T Cellular Immunotherapy Drug Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: CAR-T Cellular Immunotherapy Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based CAR-T Cellular Immunotherapy Drug Companies and Market Share, 2018-2023
        4.3.1 United States Based CAR-T Cellular Immunotherapy Drug Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies CAR-T Cellular Immunotherapy Drug Revenue, (2018-2023)
    4.4 China Based Companies CAR-T Cellular Immunotherapy Drug Revenue and Market Share, 2018-2023
        4.4.1 China Based CAR-T Cellular Immunotherapy Drug Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies CAR-T Cellular Immunotherapy Drug Revenue, (2018-2023)
    4.5 Rest of World Based CAR-T Cellular Immunotherapy Drug Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based CAR-T Cellular Immunotherapy Drug Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies CAR-T Cellular Immunotherapy Drug Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World CAR-T Cellular Immunotherapy Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 CD19-Targeted
        5.2.2 BCMA-Targeted
    5.3 Market Segment by Type
        5.3.1 World CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023)
        5.3.2 World CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029)
        5.3.3 World CAR-T Cellular Immunotherapy Drug Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World CAR-T Cellular Immunotherapy Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Multiple Myeloma
        6.2.2 Non-Hodgkin lymphoma
        6.2.3 Leukemia
    6.3 Market Segment by Application
        6.3.1 World CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023)
        6.3.2 World CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029)
        6.3.3 World CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Novartis AG
        7.1.1 Novartis AG Details
        7.1.2 Novartis AG Major Business
        7.1.3 Novartis AG CAR-T Cellular Immunotherapy Drug Product and Services
        7.1.4 Novartis AG CAR-T Cellular Immunotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Novartis AG Recent Developments/Updates
        7.1.6 Novartis AG Competitive Strengths & Weaknesses
    7.2 Kite Pharma
        7.2.1 Kite Pharma Details
        7.2.2 Kite Pharma Major Business
        7.2.3 Kite Pharma CAR-T Cellular Immunotherapy Drug Product and Services
        7.2.4 Kite Pharma CAR-T Cellular Immunotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Kite Pharma Recent Developments/Updates
        7.2.6 Kite Pharma Competitive Strengths & Weaknesses
    7.3 Bristol Myers Squibb
        7.3.1 Bristol Myers Squibb Details
        7.3.2 Bristol Myers Squibb Major Business
        7.3.3 Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Product and Services
        7.3.4 Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Bristol Myers Squibb Recent Developments/Updates
        7.3.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
    7.4 Fosun Pharma
        7.4.1 Fosun Pharma Details
        7.4.2 Fosun Pharma Major Business
        7.4.3 Fosun Pharma CAR-T Cellular Immunotherapy Drug Product and Services
        7.4.4 Fosun Pharma CAR-T Cellular Immunotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Fosun Pharma Recent Developments/Updates
        7.4.6 Fosun Pharma Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 CAR-T Cellular Immunotherapy Drug Industry Chain
    8.2 CAR-T Cellular Immunotherapy Drug Upstream Analysis
    8.3 CAR-T Cellular Immunotherapy Drug Midstream Analysis
    8.4 CAR-T Cellular Immunotherapy Drug Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World CAR-T Cellular Immunotherapy Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World CAR-T Cellular Immunotherapy Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World CAR-T Cellular Immunotherapy Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World CAR-T Cellular Immunotherapy Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World CAR-T Cellular Immunotherapy Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World CAR-T Cellular Immunotherapy Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World CAR-T Cellular Immunotherapy Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World CAR-T Cellular Immunotherapy Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World CAR-T Cellular Immunotherapy Drug Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key CAR-T Cellular Immunotherapy Drug Players in 2022
    Table 12. World CAR-T Cellular Immunotherapy Drug Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global CAR-T Cellular Immunotherapy Drug Company Evaluation Quadrant
    Table 14. Head Office of Key CAR-T Cellular Immunotherapy Drug Player
    Table 15. CAR-T Cellular Immunotherapy Drug Market: Company Product Type Footprint
    Table 16. CAR-T Cellular Immunotherapy Drug Market: Company Product Application Footprint
    Table 17. CAR-T Cellular Immunotherapy Drug Mergers & Acquisitions Activity
    Table 18. United States VS China CAR-T Cellular Immunotherapy Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China CAR-T Cellular Immunotherapy Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based CAR-T Cellular Immunotherapy Drug Companies, Headquarters (States, Country)
    Table 21. United States Based Companies CAR-T Cellular Immunotherapy Drug Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies CAR-T Cellular Immunotherapy Drug Revenue Market Share (2018-2023)
    Table 23. China Based CAR-T Cellular Immunotherapy Drug Companies, Headquarters (Province, Country)
    Table 24. China Based Companies CAR-T Cellular Immunotherapy Drug Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies CAR-T Cellular Immunotherapy Drug Revenue Market Share (2018-2023)
    Table 26. Rest of World Based CAR-T Cellular Immunotherapy Drug Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies CAR-T Cellular Immunotherapy Drug Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies CAR-T Cellular Immunotherapy Drug Revenue Market Share (2018-2023)
    Table 29. World CAR-T Cellular Immunotherapy Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World CAR-T Cellular Immunotherapy Drug Market Size by Type (2018-2023) & (USD Million)
    Table 31. World CAR-T Cellular Immunotherapy Drug Market Size by Type (2024-2029) & (USD Million)
    Table 32. World CAR-T Cellular Immunotherapy Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World CAR-T Cellular Immunotherapy Drug Market Size by Application (2018-2023) & (USD Million)
    Table 34. World CAR-T Cellular Immunotherapy Drug Market Size by Application (2024-2029) & (USD Million)
    Table 35. Novartis AG Basic Information, Area Served and Competitors
    Table 36. Novartis AG Major Business
    Table 37. Novartis AG CAR-T Cellular Immunotherapy Drug Product and Services
    Table 38. Novartis AG CAR-T Cellular Immunotherapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Novartis AG Recent Developments/Updates
    Table 40. Novartis AG Competitive Strengths & Weaknesses
    Table 41. Kite Pharma Basic Information, Area Served and Competitors
    Table 42. Kite Pharma Major Business
    Table 43. Kite Pharma CAR-T Cellular Immunotherapy Drug Product and Services
    Table 44. Kite Pharma CAR-T Cellular Immunotherapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Kite Pharma Recent Developments/Updates
    Table 46. Kite Pharma Competitive Strengths & Weaknesses
    Table 47. Bristol Myers Squibb Basic Information, Area Served and Competitors
    Table 48. Bristol Myers Squibb Major Business
    Table 49. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Product and Services
    Table 50. Bristol Myers Squibb CAR-T Cellular Immunotherapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Bristol Myers Squibb Recent Developments/Updates
    Table 52. Fosun Pharma Basic Information, Area Served and Competitors
    Table 53. Fosun Pharma Major Business
    Table 54. Fosun Pharma CAR-T Cellular Immunotherapy Drug Product and Services
    Table 55. Fosun Pharma CAR-T Cellular Immunotherapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 56. Global Key Players of CAR-T Cellular Immunotherapy Drug Upstream (Raw Materials)
    Table 57. CAR-T Cellular Immunotherapy Drug Typical Customers
List of Figure
    Figure 1. CAR-T Cellular Immunotherapy Drug Picture
    Figure 2. World CAR-T Cellular Immunotherapy Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World CAR-T Cellular Immunotherapy Drug Total Market Size (2018-2029) & (USD Million)
    Figure 4. World CAR-T Cellular Immunotherapy Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World CAR-T Cellular Immunotherapy Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company CAR-T Cellular Immunotherapy Drug Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company CAR-T Cellular Immunotherapy Drug Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company CAR-T Cellular Immunotherapy Drug Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company CAR-T Cellular Immunotherapy Drug Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company CAR-T Cellular Immunotherapy Drug Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company CAR-T Cellular Immunotherapy Drug Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company CAR-T Cellular Immunotherapy Drug Revenue (2018-2029) & (USD Million)
    Figure 13. CAR-T Cellular Immunotherapy Drug Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World CAR-T Cellular Immunotherapy Drug Consumption Value (2018-2029) & (USD Million)
    Figure 16. World CAR-T Cellular Immunotherapy Drug Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States CAR-T Cellular Immunotherapy Drug Consumption Value (2018-2029) & (USD Million)
    Figure 18. China CAR-T Cellular Immunotherapy Drug Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe CAR-T Cellular Immunotherapy Drug Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan CAR-T Cellular Immunotherapy Drug Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea CAR-T Cellular Immunotherapy Drug Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN CAR-T Cellular Immunotherapy Drug Consumption Value (2018-2029) & (USD Million)
    Figure 23. India CAR-T Cellular Immunotherapy Drug Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of CAR-T Cellular Immunotherapy Drug by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for CAR-T Cellular Immunotherapy Drug Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for CAR-T Cellular Immunotherapy Drug Markets in 2022
    Figure 27. United States VS China: CAR-T Cellular Immunotherapy Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: CAR-T Cellular Immunotherapy Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World CAR-T Cellular Immunotherapy Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World CAR-T Cellular Immunotherapy Drug Market Size Market Share by Type in 2022
    Figure 31. CD19-Targeted
    Figure 32. BCMA-Targeted
    Figure 33. World CAR-T Cellular Immunotherapy Drug Market Size Market Share by Type (2018-2029)
    Figure 34. World CAR-T Cellular Immunotherapy Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World CAR-T Cellular Immunotherapy Drug Market Size Market Share by Application in 2022
    Figure 36. Multiple Myeloma
    Figure 37. Non-Hodgkin lymphoma
    Figure 38. Leukemia
    Figure 39. CAR-T Cellular Immunotherapy Drug Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novartis AG
Kite Pharma
Bristol Myers Squibb
Fosun Pharma

Related Reports

Global CAR-T Cellular Immunotherapy Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global CAR-T Cellular Immunotherapy Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 02 Sep 2023

date Medical Care

According to our (Global Info Research) latest study, the global CAR-T Cellular Immunotherapy Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global CAR-T Cellular Immunotherapy Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global CAR-T Cellular Immunotherapy Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global CAR-T Cellular Immunotherapy Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global CAR-T Cellular Immunotherapy Drug Supply, Demand and Key Producers, 2024-2030

Global CAR-T Cellular Immunotherapy Drug Supply, Demand and Key Producers, 2024-2030

date 09 Feb 2024

date Medical Care

The global CAR-T Cellular Immunotherapy Drug market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

CAR-T Cellular Immunotherapy Drug

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>